Advanced Biomed Inc. Statistics
Advanced Biomed Inc. (ADVB) Stock Statistics & Valuation Metrics
Total Valuation
Advanced Biomed Inc. has a market cap or net worth of $5.47M. The enterprise value is $5.08T.
- Market Cap
- $5.47M
- Enterprise Value
- $5.08T
Share Statistics
Advanced Biomed Inc. has 1,652,133 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,652,133
- Owned by Insiders
- ―
- Owned by Institutions
- 1.34%
Financial Efficiency
Advanced Biomed Inc.’s return on equity (ROE) is 0.54 and return on invested capital (ROIC) is -50.63%.
- Return on Equity (ROE)
- 0.54
- Return on Assets (ROA)
- 0.49
- Return on Invested Capital (ROIC)
- -50.63%
- Return on Capital Employed (ROCE)
- -0.51
- Revenue Per Employee
- 10.64K
- Profits Per Employee
- 556.42K
- Employee Count
- 12
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Advanced Biomed Inc. is -21.08. Advanced Biomed Inc.’s PEG ratio is -0.11.
- PE Ratio
- -21.08
- PS Ratio
- 32.75
- PB Ratio
- 0.37
- Price to FCF
- -5.37
- Price to Operating Cash Flow
- -5.38
- PEG Ratio
- -0.11
Income Statement
In the last 12 months, Advanced Biomed Inc. had revenue of 127.64K and earned 6.68M in profits. Earnings per share was 5.33.
- Revenue
- 127.64K
- Gross Profit
- -6.23M
- Operating Income
- -6.23M
- Pretax Income
- -6.26M
- Net Income
- 6.68M
- EBITDA
- -6.26M
- Earnings Per Share (EPS)
- 5.33
Cash Flow
In the last 12 months, operating cash flow was -777.44K and capital expenditures -454, giving a free cash flow of -777.89K billion.
- Operating Cash Flow
- -777.44K
- Free Cash Flow
- -777.89K
- Free Cash Flow per Share
- -0.47
Dividends & Yields
Advanced Biomed Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -18.11%
- Earnings Yield
- 141.42%
Stock Price Statistics
- Beta
- 0.81
- 52-Week Price Change
- -71.77%
- 50-Day Moving Average
- 5.37
- 200-Day Moving Average
- 5.75
- Relative Strength Index (RSI)
- 39.20
- Average Volume (3m)
- 99.19K
Financial Position
Advanced Biomed Inc. as a current ratio of 9.33, with Debt / Equity ratio of 0.28%
- Current Ratio
- 9.33
- Quick Ratio
- 9.33
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.06
- Interest Coverage Ratio
- -888.73
Taxes
In the past 12 months, Advanced Biomed Inc. has paid -1,205 in taxes.
- Income Tax
- -1,205
- Effective Tax Rate
- 0.00
Enterprise Valuation
Advanced Biomed Inc. EV to EBITDA ratio is -0.59, with an EV/FCF ratio of -5.28.
- EV to Sales
- 32.16
- EV to EBITDA
- -0.59
- EV to Free Cash Flow
- -5.28
- EV to Operating Cash Flow
- -5.28
Balance Sheet
Advanced Biomed Inc. has $214.00K in cash and marketable securities with $0.00 in debt, giving a net cash position of $214.00K billion.
- Cash & Marketable Securities
- $214.00K
- Total Debt
- $0.00
- Net Cash
- $214.00K
- Net Cash Per Share
- $0.13
- Tangible Book Value Per Share
- $6.83
Margins
Gross margin is -4619.44%, with operating margin of -5337.48%, and net profit margin of 4759.53%.
- Gross Margin
- -4619.44%
- Operating Margin
- -5337.48%
- Pretax Margin
- -5478.71%
- Net Profit Margin
- 4759.53%
- EBITDA Margin
- -5442.64%
- EBIT Margin
- -5461.27%
Analyst Forecast
The average price target for Advanced Biomed Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 11.25%
